Financial Enhancement Group LLC Johnson & Johnson Transaction History

Financial Enhancement Group LLC

$569 Million
Q3 2024

A detailed history of Financial Enhancement Group LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Financial Enhancement Group LLC holds 1,707 shares of JNJ stock, worth $248,965. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,707

Previous 1,565 9.07%

Holding current value

$248,965

Previous $228,000 21.05%

% of portfolio

0.05%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$145.48 - $167.38 $20,658 - $23,767	142 Added 9.07%	1,707 $276,000
Q2 2024 Aug 02, 2024	BUY	$144.38 - $157.78 $866 - $946	6 Added 0.38%	1,565 $228,000
Q1 2024 Apr 15, 2024	BUY	$155.22 - $162.74 $5,898 - $6,184	38 Added 2.5%	1,559 $246,000
Q4 2023 Jan 18, 2024	SELL	$145.6 - $158.88 $98,716 - $107,720	-678 Reduced 30.83%	1,521 $238,000
Q3 2023 Oct 17, 2023	BUY	$155.75 - $174.48 $23,362 - $26,172	150 Added 7.32%	2,199 $342,000
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $52,787 - $56,809	342 Added 20.04%	2,049 $339,000
Q1 2023 May 17, 2023	BUY	$151.05 - $180.26 $7,854 - $9,373	52 Added 3.14%	1,707 $264,000
Q4 2022 Feb 09, 2023	SELL	$160.2 - $179.79 $8,009 - $8,989	-50 Reduced 2.93%	1,655 $292,000
Q1 2022 May 18, 2022	BUY	$158.14 - $179.59 $8,065 - $9,159	51 Added 3.08%	1,705 $302,000
Q4 2021 Jan 28, 2022	SELL	$155.93 - $173.01 $20,426 - $22,664	-131 Reduced 7.34%	1,654 $283,000
Q3 2021 Oct 14, 2021	BUY	$161.5 - $179.47 $183,787 - $204,236	1,138 Added 175.89%	1,785 $288,000
Q2 2021 Aug 10, 2021	SELL	$159.48 - $171.07 $14,512 - $15,567	-91 Reduced 12.33%	647 $107,000
Q1 2021 May 10, 2021	SELL	$153.07 - $170.48 $13,010 - $14,490	-85 Reduced 10.33%	738 $121,000
Q4 2020 Feb 10, 2021	BUY	$137.11 - $157.38 $137 - $157	1 Added 0.12%	823 $130,000
Q1 2020 May 04, 2020	SELL	$111.14 - $153.99 $13,336 - $18,478	-120 Reduced 12.74%	822 $108,000
Q4 2019 Jan 31, 2020	SELL	$127.5 - $146.44 $1,020 - $1,171	-8 Reduced 0.84%	942 $137,000
Q3 2019 Nov 08, 2019	BUY	$126.95 - $142.14 $23,358 - $26,153	184 Added 24.02%	950 $123,000
Q2 2019 Aug 06, 2019	SELL	$131.15 - $144.24 $26,361 - $28,992	-201 Reduced 20.79%	766 $107,000
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $55,442 - $61,647	441 Added 83.84%	967 $135,000
Q3 2018 Nov 19, 2018	SELL	$121.58 - $142.88 $10,699 - $12,573	-88 Reduced 14.33%	526 $73,000
Q2 2018 Aug 08, 2018	SELL	$119.4 - $131.76 $22,805 - $25,166	-191 Reduced 23.73%	614 $75,000
Q1 2018 Apr 30, 2018	BUY	$125.1 - $148.14 $100,705 - $119,252	805 New	805 $103,000

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Enhancement Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Financial Enhancement Group LLC with notifications on news.

Account

Financial Enhancement Group LLC Johnson & Johnson Transaction History